Nuzenio

Drug Designation

Drug Designation news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 11 publisher sources 100/100 entity strength

Latest news

FDA grants orphan drug status to potential treatment for ALL - Rare Cancer NewsRare Cancer News · Fri, 07 Aug 2026 18:08:50 GMT Nieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - OncodailyOncodaily · Fri, 07 Aug 2026 11:52:07 GMT IPS HEART Secures 8th FDA Regulatory Milestone with Rare Pediatric Drug Designation for Cardiomyopathy Associated with Muscular Dystrophies - BioSpaceBioSpace · Thu, 06 Aug 2026 16:36:30 GMT Does New US Orphan Drug Status For Zoci Reshape The Bull Case For Zai Lab (ZLAB)? - simplywall.stsimplywall.st · Wed, 05 Aug 2026 20:41:09 GMT FDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted OncologyTargeted Oncology · Wed, 05 Aug 2026 16:09:36 GMT FDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSciAllSci · Tue, 04 Aug 2026 12:20:33 GMT FDA Grants Orphan Drug Designation to Zocilurtatug Pelitecan for Neuroendocrine Carcinomas - OncLiveOncLive · Mon, 03 Aug 2026 15:59:22 GMT FDA Fast Track and Priority Review Designations Granted in July 2026 - Oncology News CentralOncology News Central · Mon, 03 Aug 2026 13:59:35 GMT

Timeline

Fri, 07 Aug 2026 18:08:50 GMTFDA grants orphan drug status to potential treatment for ALL - Rare Cancer News

Fri, 07 Aug 2026 11:52:07 GMTNieves Martinez Lago: FDA Grants Orphan Drug Designation to DLL3-Targeting ADC Zoci for NECs - Oncodaily

Thu, 06 Aug 2026 16:36:30 GMTIPS HEART Secures 8th FDA Regulatory Milestone with Rare Pediatric Drug Designation for Cardiomyopathy Associated with Muscular Dystrophies - BioSpace

Wed, 05 Aug 2026 20:41:09 GMTDoes New US Orphan Drug Status For Zoci Reshape The Bull Case For Zai Lab (ZLAB)? - simplywall.st

Wed, 05 Aug 2026 16:09:36 GMTFDA Names Zocilurtatug Pelitecan Orphan Drug in Neuroendocrine Carcinomas - Targeted Oncology

Tue, 04 Aug 2026 12:20:33 GMTFDA grants orphan drug designation to Zai Lab's zoci for neuroendocrine carcinomas - AllSci

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

FDA6 live mentions FDA Grants Orphan5 live mentions Designation5 live mentions Neuroendocrine Carcinomas4 live mentions Zai Lab4 live mentions FDA Fast Track4 live mentions Treatment4 live mentions NECs3 live mentions Oncology News Central3 live mentions Pulmonary Hypertension News3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Drug Designation.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.